My clinical expertise is in Molecular Pathology. The clinical laboratory I direct is a full service CLIA certified molecular pathology laboratory that encompasses testing in all areas including oncology (hematological and solid tumor), infectious diseases, genetics, hereditary and somatic pharmacogenetics, and identity testing. Currently we have a major emphasis on the development of oncology-based tests including somatic pharmacogenetics. Somatic pharmacogenetics represents somatic changes in tumors that make them more or less susceptible to therapeutic approaches. With the development of new targeted therapies, this type of molecular oncology testing is ever more critical for clinical management of patients. Other areas of growth include molecular infectious disease testing.
In addition, our Department and Lab sponsor a fellowship training program in Molecular Genetic Pathology to train the next generation of molecular laboratory directors and surgical pathologists with expertise in the integration of molecular technologies into the practice of pathology.